Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].
作者信息
Gil-Jimenez Alberto, van Dorp Jeroen, Contreras-Sanz Alberto, van der Vos Kristan, Vis Daniel J, Braaf Linde, Broeks Annegien, Kerkhoven Ron, van Kessel Kim E M, Ribal María José, Alcaraz Antonio, Wessels Lodewyk F A, Seiler Roland, Wright Jonathan L, Mengual Lourdes, Boormans Joost, van Rhijn Bas W G, Black Peter C, van der Heijden Michiel S
机构信息
Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.
Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
出版信息
Eur Urol. 2023 Jun;83(6):e165. doi: 10.1016/j.eururo.2023.03.002. Epub 2023 Mar 10.
PMID:36907692
Abstract
摘要
Zotero 插件